Healthcare

Antibody Drug Conjugates Contract Market Is Accounted To Give An Absolute Dollar Opportunity Growth Of Nearly US$ 29.7 Billion By 2032

Newly-released Antibody Drug Conjugates Contract Market industry analysis report by Fact.MR shows that global sales of the Antibody Drug Conjugates Contract Market in 2021 were held at US$ 8.1 Bn. With a CAGR of 15.5 %, the projected market growth during the period 2022-2032 is expected to be slightly higher than the historical growth which stood at 12.7%. The Antibody Drug Conjugates Contract Market is accounted to

Healthcare

Animal Genetics Market Growth, With An Anticipated CAGR Of 6% By 2032

Recent advancements in genomic technology are extending the frontiers of innovation in livestock production. Easy availability of molecular tools and enzymes, such as Digital Polymerase Chain Reaction (dPCR), to extract vital information about livestock species, is increasing the possibilities to develop embryos of desired gender and traits. The livestock revolution trend is found to complement

Healthcare

Cardiac Resynchronization Therapy Market Is Expected To Achieve A Market Value Of US$ 6.2 Billion By 2022

Cardiac Resynchronization Therapy Market Analysis by Product Type (CRT-Defibrillator, RT-Pacemaker), by End-user Type, by Region – Global Forecast 2022-2032 Newly-released Cardiac Resynchronization Therapy industry analysis report by Fact.MR shows that global sales of Cardiac Resynchronization Therapy in 2021 were held at US$ 5.7 Bn. With 7.9%, the projected market growth during 2022-2032 is expected to be slightly

Healthcare

Non-Invasive Aesthetic Treatment Market Is Expected To Grow With The Compound Annual Growth Rate CAGR Of 16.5% By 2032

The revenue from injectables in 2021 was US$ 33.8 Bn and is expected to grow above 5X during the forecast period. The demand for injectables primarily comes from North America, Europe and APAC region, and these three regions collectively generated more than 85% revenue of injectables. The non-Invasive aesthetic market revenues were estimated at US$

Healthcare

Global Antibodies Market Is Expected To Surpass A Valuation Of Us$ 3,000 Mn By End Of 2022

As of 2022, the global antibodies market is valued at US$ 197.3 billion and is projected to exhibit expansion at a stellar CAGR of 11.9% over the next ten years. The market is anticipated to bloat 3X to surpass a valuation of US$ 608 billion by the end of 2032. Antibodies have various purposes including diagnostics along with other therapeutic purposes like indication